Daniel Petrylak, MD
Yale Cancer Center/Smilow Cancer Hospital

Disclosure of Relevant Financial Relationships
All faculty and activity planners participating in NCCN continuing education activities are expected to disclose any relevant financial relationships with a commercial interest as defined by the ACCME’s, ANCC’s, and ACPE’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.

The faculty listed below have disclosed the following relevant financial relationships:

Daniel Petrylak, MD
Agenysis, Inc. Grant/Research Support
Bayer HealthCare: Consulting Fees, Honoraria
Bellicum Pharmaceuticals, Inc.: Consulting Fees, Honoraria
Celgene Corporation: Grant/Research Support
Dendreon Corporation: Consulting Fees, Honoraria; Grant/Research Support
Eli Lilly and Company: Grant/Research Support
Exelixis Inc.: Consulting Fees, Honoraria
Ferring Pharmaceuticals, Inc. Consulting Fees, Honoraria
Johnson & Johnson Consulting Fees, Honoraria; Grant/Research Support
Medivation, Inc.: Consulting Fees, Honoraria
Millennium Pharmaceuticals, Inc.: Consulting Fees, Honoraria; Grant/Research Support
OncoGenex Pharmaceuticals Inc.: Grant/Research Support
Pfizer Inc.: Consulting Fees, Honoraria
Progenics Pharmaceuticals, Inc: Grant/Research Support
Roche Laboratories, Inc: Consulting Fees, Honoraria; Grant/Research Support
sanofi-aventis U.S.: Consulting Fees, Honoraria; Grant/Research Support
Tyme Inc: Consulting Fees, Honoraria

NCCN Staff Disclosures
The activity planning staff listed below has no relevant financial relationships to disclose:
Ann Gianola, MA; Mark Geisler; Kristina M. Gregory, RN, MSN, OCN; Kristin Kline Hasson; Rose Joyce; Joan S. McClure, MS; Diane McPherson; Deborah Moonan, RN, BSN; Liz Rieder; Shannon K. Ryan; Jennifer McCann Weckesser

The NCCN clinical information team listed below, who have reviewed content, has no relevant financial relationships to disclose:
Mary Dwyer, MS; Rashmi Kumar, PhD

The NCCN clinical information team listed below, who have reviewed content, has the following relevant financial relationships to disclose:

Courtney Smith, PhD
Johnson & Johnson: Equity Interest/Stock Options
Opko Health Inc: Equity Interest/Stock Options

The ACCME/ANCC/ACPE defines “conflict of interest” as when an individual has an opportunity to affect CE content about products or services of a commercial interest with which he/she has a financial relationship.

ACCME, ACPE, and ANCC focuses on financial relationships with commercial interests in the 12-month period preceding the time that the individual is being asked to assume a role controlling content of the CE activity. ACCME, ACPE, and ANCC have not set a minimal dollar amount for relationships to be significant. Inherent in any amount is the incentive to maintain or increase the value of the relationship. The ACCME, ACPE, and ANCC defines “’relevant’ financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.

All faculty for this continuing education activity are competent in the subject matter and qualified by experience, training, and/or preparation to the tasks and methods of delivery.